Longview Partners (Guernsey) LTD

Institutional investor · Portfolio as of Q2 2026

Top Holdings23 positions

Checking export access…
Activity:
WST

West Pharmaceutical Services, Inc.

1M$371.1M6.0%$267.46+53.78%
4 qtrssince 2025-Q3
Decreased
0
UNH

UnitedHealth Group Incorporated

842,497$350.2M5.7%$288.57+40.39%
30 qtrssince 2019-Q1
Decreased
0
TSM
TSM
ADR

Taiwan Semiconductor Manufacturing Company Ltd.

706,120$337.2M5.5%$336.26+17.91%
2 qtrssince 2026-Q1
Decreased
0
TXN

Texas Instruments Incorporated

1.1M$322.3M5.2%$191.24+57.14%
2 qtrssince 2026-Q1
Decreased
0
GOOGL

Alphabet Inc.

827,249$295.6M4.8%$74.61+300.32%
25 qtrssince 2020-Q2
Decreased
0
IQV

IQVIA Holdings, Inc.

1.5M$290M4.7%$127.27+113.02%
26 qtrssince 2020-Q1
Decreased
0
AXP

American Express Company

849,396$287.3M4.7%$84.72+275.43%
27 qtrssince 2019-Q4
Decreased
0
COO

The Cooper Companies, Inc.

3.9M$282.5M4.6%$71.51-13.03%
2 qtrssince 2026-Q1
Increased
59
V

Visa Inc.

817,595$280.5M4.6%$219.64+92.58%
14 qtrssince 2023-Q1
Decreased
0
PGR

The Progressive Corporation

1.2M$266.4M4.3%$218.25+6.19%
1 qtr
New
86
TMO

Thermo Fisher Scientific Inc

529,776$265.6M4.3%$525.08+33.21%
11 qtrssince 2023-Q4
Decreased
0
CDW

CDW Corporation

1.9M$262.7M4.3%$171.29+0.87%
19 qtrssince 2021-Q4
Decreased
0
BKNG

Booking Holdings Inc.

1.5M$262.6M4.3%$65.28+146.94%
16 qtrssince 2022-Q3
Decreased
0
MSCI

MSCI Inc.

463,710$259.7M4.2%$559.76+16.39%
5 qtrssince 2025-Q2
Decreased
0
SYY

Sysco Corporation

3.1M$257.9M4.2%$56.01+36.11%
28 qtrssince 2019-Q3
Decreased
0
BDX

Becton, Dickinson and Company

1.7M$255.8M4.2%——
22 qtrssince 2021-Q1
Decreased
0
AON

Aon plc

768,975$255.1M4.1%$192.39+73.30%
25 qtrssince 2020-Q2
Decreased
0
MCO

Moody's Corporation

558,785$253.1M4.1%$268.25+88.84%
18 qtrssince 2022-Q1
Decreased
0
FIS

Fidelity National Information Services, Inc.

6.3M$244.3M4.0%$49.54-42.75%
13 qtrssince 2023-Q2
Increased
64
MSFT

Microsoft Corporation

645,228$240.7M3.9%$250.08+113.20%
17 qtrssince 2022-Q2
Decreased
0
$6.2B
AUM
23
Positions
Q2 2026
Filing
HI rating · 4.5/5
Quarterly 13F Value Change
Reported 13F value ($B)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2025-Q1$12,428,201,485-7.1889641202%
2025-Q2$11,606,071,163-6.61503857169%
2025-Q3$9,568,286,933-17.5579160371%
2025-Q4$9,575,962,9630.0802236602409%
2026-Q1$7,058,047,343-26.2941244628%
2026-Q2$6,157,423,346-12.7602430705%
Activity profile
$ moved · Q2'26
New15%Increased2%Decreased52%Exited32%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.6 years
<1Q4%1-4Q22%1-2Y9%2Y+65%

Longview Partners (Guernsey) LTD manages $6.2B across 23 positions as of Q2 2026. Top holdings: WST (6.0%), UNH (5.7%), TSM (5.5%). Fund DNA: Steady Compounder. HoldingsIntel Score: 4.5/5.0.

Q2 2026 Summary

Added PGR; exited NKE, FISV and MRSH; increased 2, led by FIS (+687,109 shares); trimmed 20, led by TXN (−437,385 shares). Top move: PGR (NEW, conviction 86). Portfolio: $6.2B across 23 positions.

Top holdings by portfolio weight

Total AUM$6B
WST6.03%
UNH5.69%
TSM5.48%
TXN5.23%
GOOGL4.80%
IQV4.71%
AXP4.67%
COO4.59%
V4.56%
PGR4.33%
Other4.31%

Portfolio allocation by GICS sector

Sectors6
Financial Services31.38%
Healthcare29.48%
Technology25.89%
Communication Services4.80%
Consumer Cyclical4.26%
Consumer Defensive4.19%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Financial Services, Healthcare, Technology
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Elite(4.5 / 5.0)
Holdings P&L83
Conviction71
Concentration75
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used